-- Looming Deadline Puts Pressure on Pharmacies Nationwide
As the final phase of the Drug Supply Chain Security Act (DSCSA) reaches enforcement in November 2025, MedTrax Inc, a U.S.-based compliance software company, has offered its end-to-end DSCSA platform tailored for pharmacies and dispensers at significant discounts to assist in achieving compliance. Designed to meet the legislation's stringent security and interoperability standards, MedTrax empowers pharmacies to maintain full compliance with electronic pedigree requirements, suspicious product reporting, and secure trading partner verification.The DSCSA, enacted in 2013 by the U.S. Congress to safeguard Americans from counterfeit and unsafe medications, requires all supply chain participants—manufacturers, wholesalers, and dispensers—to adopt digital, secure, and traceable systems. Enforcement efforts by the U.S. Food and Drug Administration (FDA) have already resulted in violations for several facilities, underscoring the urgency for compliance.
Understanding the Law: What DSCSA Requires
The DSCSA is one of the most comprehensive pharmaceutical traceability laws passed in the last decade. By November 2025, the following mandates will apply:
Manufacturers and wholesalers must provide electronic pedigree (proof of manufacture) documents to purchasers.
Dispensers (pharmacies) must store and manage pedigree files in a secure, interoperable database.
All systems must ensure:
- Secure, encrypted data transfers.
- Individual user account protections with 2-factor authentication.
- Audit logs that record all data changes with timestamps and user identification.
- Verification of authorized trading partners.
- 24/7 data availability.
- Electronic filing of FDA Form 3911 to report suspicious or illegitimate drugs.
- Minimum 6-year data retention.
The Risks of Non-Compliance
The FDA has already begun issuing enforcement actions against major distributors and pharmacies:
- McKesson Health San Francisco failed to report tampered products.
- Safe Chain Solutions engaged with unauthorized trading partners and failed to report suspicious items.
- Valisure did not properly investigate or report suspect products to the FDA.
- Penalties for non-compliance range from fines to license revocation and criminal charges.
MedTrax: Simplifying Compliance with Secure Technology
MedTrax Inc offers a streamlined solution to meet the complex needs of DSCSA compliance. Designed with input from experienced pharmacists and backed by decades of recall and reverse distribution support via Outdate Rx, the MedTrax system addresses every critical component of the law.
Key features include:
- 2-Factor authentication and encrypted AS2 data transmissions to protect sensitive records.
- Multi-scan technology to process full shipments with a single scan.
- Electronic Product Code Information Services (EPCIS) data allows tracking in three dimensions—origin, co-shipment, and destination.
- Real-time Form 3911 filing and instant recall alerts based on National Recall Alert Center data.
- Automated partner verification and secure account access protocols.
- System integrations that turn compliance into a background task with minimal disruption to workflow.
The system's reliability is reinforced with redundant backups and continuous system logging to ensure accountability and peace of mind for users.
National Recognition: MedTrax Wins Best New Tech Company of 2025
Adding to its momentum, MedTrax Inc has been named the Best New Tech Company in the U.S. of 2025 by the Evergreen Awards, a national program that highlights innovation and excellence in the technology sector. The award distinguishes MedTrax as a standout in healthcare technology for its comprehensive approach to compliance and its forward-thinking platform that helps pharmacies meet federal mandates while improving operational performance.
The award committee recognized MedTrax’s secure infrastructure, robust audit capabilities, and the inclusion of scalable compliance workflows that align with real-world pharmacy operations. By integrating features such as redundant cloud storage, configurable audit trails, and system logging, MedTrax was celebrated for offering a purpose-built solution rooted in industry expertise.
“We designed this to solve real problems pharmacists face—not just to check regulatory boxes,” said Jacob Record, President of MedTrax Inc. “This recognition confirms we’re heading in the right direction.”
Leveraging Deep Industry Insight
What separates MedTrax from other emerging DSCSA software providers is its foundational knowledge of pharmacy operations. Drawing from years of experience in recall management and compliance services through its affiliation with Outdate Rx, MedTrax was built to mirror the real-world needs of pharmacy teams.
“We’ve helped pharmacies for decades,” said Jacob Record, President of MedTrax Inc. “Our experience has shown us where the friction points are, and we built MedTrax to eliminate them. We’re not just tech developers; we’re pharmacy advocates.”
Unlike other providers who focus solely on compliance checklists, MedTrax integrates business-saving features such as expired medication processing and customized recall alerts to offer greater operational value.
Compliance That Pays for Itself
While other solutions may focus on functionality, MedTrax ensures compliance is both achievable and affordable. With a flat-rate subscription that costs about a dollar per day, the platform is positioned as an essential utility for pharmacies navigating an increasingly regulated environment.
“Our partnerships and scale let us offer unbeatable value,” said Record. “And we’ve already built the connections with wholesalers and manufacturers to make onboarding painless.”
With thousands of pharmacies still unaware or underprepared for the DSCSA's final phase, MedTrax hopes this announcement will not only spread awareness but offer an actionable solution before the November deadline.
About MedTrax Inc
MedTrax Inc provides DSCSA compliance software designed for dispensers and pharmacy operations. Headquartered in the United States and backed by the team at Outdate Rx, MedTrax leverages decades of recall and distribution compliance experience to develop intuitive, secure systems that meet federal requirements. The company’s technology is engineered to support pharmacies in meeting every aspect of the Drug Supply Chain Security Act.
For more information and a special pricing offer, visit www.medtrax.com/promo
Media Contact
Jacob Record
President, MedTrax Inc
Phone: 855-863-3872
Email: [email protected]
Contact Info:
Name: Jacob Record
Email: Send Email
Organization: MedTrax Inc
Website: http://www.medtrax.com/promo
Release ID: 89158323